The cyclooxygenase-2/prostaglandin E2 pathway is involved in the somatostatin-induced decrease of epileptiform bursting in the mouse hippocampus.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neuropharmacology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2008.01.008PMID 18329054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel anticonvulsant drugs.

  2007cited by this paper
• Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages

  2007cited by this paper
• GABA excitation in mouse hilar neuropeptide Y neurons

  2007cited by this paper
• An update on somatostatin receptor signaling in native systems and new insights on their pathophysiology.

  2007cited by this paper
• Endocannabinoids block status epilepticus in cultured hippocampal neurons.

  2007cited by this paper
• Selective loss of dentate hilar interneurons contributes to reduced synaptic inhibition of granule cells in an electrical stimulation‐based animal model of temporal lobe epilepsy

  2007cited by this paper
• Cytosolic phospholipase A2 alpha mediates electrophysiologic responses of hippocampal pyramidal neurons to neurotoxic NMDA treatment

  2007cited by this paper
• Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system.

  2006influential reference
• Novel anticonvulsant drugs targeting voltage-dependent ion channels

  2006cited by this paper
• Prostaglandin E2 produced by late induced COX-2 stimulates hippocampal neuron loss after seizure in the CA3 region.

  2006influential reference
• Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders.

  2006cited by this paper
• Cytosolic phospholipase A2 alpha modulates NMDA neurotoxicity in mouse hippocampal cultures

  2006cited by this paper
• Molecular Signaling Mechanisms Underlying Epileptogenesis

  2006cited by this paper
• Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission

  2006influential reference
• Prostaglandin E2 and BDNF levels in rat hippocampus are negatively correlated with status epilepticus severity: no impact on survival of seizure-generated neurons.

  2006cited by this paper
• Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.

  2005influential reference
• Multiple facets of GABAergic neurons and synapses: multiple fates of GABA signalling in epilepsies.

  2005cited by this paper
• Lipid signaling: sleep, synaptic plasticity, and neuroprotection.

  2005influential reference
• Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.

  2005influential reference
• Brain Inflammation in Epilepsy: Experimental and Clinical Evidence

  2005cited by this paper
• Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.

  2005cited by this paper
• Lipid Signaling in Experimental Epilepsy

  2005cited by this paper
• Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 Receptor

  2005cited by this paper
• Phosphorylation of AMPA receptor subunits is differentially regulated by phospholipase A2 inhibitors.

  2005cited by this paper
• AMPA receptor phosphorylation is selectively regulated by constitutive phospholipase A2 and 5‐lipoxygenase activities

  2005cited by this paper
• Cyclo‐oxygenase‐1 and ‐2 differently contribute to prostaglandin E2 synthesis and lipid peroxidation after in vivo activation of N‐methyl‐d‐aspartate receptors in rat hippocampus

  2005cited by this paper
• Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons.

  2005influential reference
• TT232, A Novel Signal Transduction Inhibitory Compound in the Therapy of Cancer and Inflammatory Diseases

  2005cited by this paper
• Cyclooxygenase-2 expression is induced in rat brain after kainate-induced seizures and promotes neuronal death in CA3 hippocampus.

  2005influential reference
• Multiple Signalling Transduction Mechanisms Differentially Coupled to Somatostatin Receptor Subtypes: A Current View

  2005influential reference
• Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration.

  2004cited by this paper
• Temporal patterns of the cerebral inflammatory response in the rat lithium-pilocarpine model of temporal lobe epilepsy.

  2004cited by this paper
• Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices

  2004influential reference
• Patterns of colocalization of neuronal nitric oxide synthase and somatostatin-like immunoreactivity in the mouse hippocampus: quantitative analysis with optical disector.

  2004cited by this paper
• Immunocytochemically defined interneuron populations in the hippocampus of mouse strains used in transgenic technology

  2004cited by this paper
• Interneuron Diversity series: Interneuronal neuropeptides--endogenous regulators of neuronal excitability.

  2004cited by this paper
• On the Role of Somatostatin in Seizure Control: Clues from the Hippocampus

  2003cited by this paper
• Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling.

  2003cited by this paper
• Opportunities in somatostatin research: biological, chemical and therapeutic aspects

  2003cited by this paper
• Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex.

  2003cited by this paper
• Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release

  2002influential reference
• Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice

  2002cited by this paper
• Cyclooxygenase-2 regulates prostaglandin E2 signaling in hippocampal long-term synaptic plasticity.

  2002cited by this paper
• Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages.

  2002cited by this paper
• Heightened seizure severity in somatostatin knockout mice.

  2002cited by this paper
• γ‐Aminobutyric acidA neurotransmission and cerebral ischemia

  2001cited by this paper
• Do Interictal Discharges Promote or Control Seizures? Experimental Evidence from an In Vitro Model of Epileptiform Discharge

  2001cited by this paper
• gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia.

  2001cited by this paper
• A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus.

  2000cited by this paper
• Somatostatin acts in CA1 and CA3 to reduce hippocampal epileptiform activity.

  1999cited by this paper
• Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis

  1999cited by this paper
• Somatostatin increases a voltage-insensitive K+ conductance in rat CA1 hippocampal neurons.

  1998cited by this paper
• Cyclooxygenases 1 and 2.

  1998influential reference
• Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus.

  1997cited by this paper
• Local production of oxygen free radicals and nitric oxide in rat diaphragm during sepsis: effects of pentoxifylline and somatostatin.

  1997cited by this paper
• Somatostatin Inhibits Excitatory Transmission at Rat Hippocampal Synapses via Presynaptic Receptors

  1997cited by this paper
• Differential Subcellular Regulation of NMDAR1 Protein and mRNA in Dendrites of Dentate Gyrus Granule Cells after Perforant Path Transection

  1997cited by this paper
• Circuit-specific alterations of N-methyl-D-aspartate receptor subunit 1 in the dentate gyrus of aged monkeys.

  1996cited by this paper
• Differential Regulation of NMDAR1 mRNA and Protein by Estradiol in the Rat Hippocampus

  1996cited by this paper
• Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids.

  1993influential reference

• Noninvasive transcranial focal stimulation affects the convulsive seizure-induced P-glycoprotein expression and function in rats.

  2020cites this paper
• Molecular and Cellular Mechanisms Underlying Somatostatin-Based Signaling in Two Model Neural Networks, the Retina and the Hippocampus

  2019cites this paper
• Transition in subicular burst firing neurons from epileptiform activity to suppressed state by feedforward inhibition

  2013cites this paper
• Vascular endothelial growth factor up‐regulation in the mouse hippocampus and its role in the control of epileptiform activity

  2011cites this paper
• Introduction of a Novel Molecular Mechanism of Epilepsy Progression: Roles of Growth Hormone Signaling in a Mouse Model of Temporal Lobe Epilepsy

  2011cites this paper
• Species-difference of cyclooxygenase-2 in the hippocampus of rodents.

  2010cites this paper
• Distinct role of growth hormone on epilepsy progression in a model of temporal lobe epilepsy

  2009cites this paper
• Cyclooxygenase in epilepsy: from perception to application.

  2009cites this paper
• Functional effects of somatostatin receptor 1 activation on synaptic transmission in the mouse hippocampus

  2009influential citation
• Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus

  2008influential citation